Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar, TNF alpha inhibitor medicine, across multiple markets globally.
At Zentiva, we provide health and wellbeing
for all generations
News from Zentiva
-
July 9, 2025 / 2025
-
June 30, 2025 / 2025
As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders, and partners for its annual meeting in Brussels.
-
June 16, 2025 / 2025
Propol2 EMF, Ruscoven, Serenil, Fisiodepur and Finocarbo will become part of Zentiva’s portfolio
-
May 30, 2025 / 2025
At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.
-
May 21, 2025 / 2025
Zentiva supported Euractiv’s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All.”
-
May 15, 2025 / 2025
Zentiva proudly participated in the 93rd European Atherosclerosis Society (EAS) Congress, held in Glasgow from May 4-7, 2025.
-
July 9, 2025 / 2025
Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar, TNF alpha inhibitor medicine, across multiple markets globally.
-
June 30, 2025 / 2025
As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders, and partners for its annual meeting in Brussels.
-
June 16, 2025 / 2025
Propol2 EMF, Ruscoven, Serenil, Fisiodepur and Finocarbo will become part of Zentiva’s portfolio
-
May 30, 2025 / 2025
At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.
-
May 21, 2025 / 2025
Zentiva supported Euractiv’s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All.”
-
May 15, 2025 / 2025
Zentiva proudly participated in the 93rd European Atherosclerosis Society (EAS) Congress, held in Glasgow from May 4-7, 2025.
-
December 17, 2024 / 2024
Key takeaways included the emerging risk of medicine shortages. This not only contradicts the solidarity principle of the European Union but also burdens the industry with added costs and administrative demands.
-
December 9, 2024 / 2024
-
November 18, 2024 / 2024
-
November 12, 2024 / 2024
We are proud to announce that Zentiva has successfully achieved the SAP Customer Center of Expertise (CCoE) certification.
-
November 8, 2024 / 2024
In this episode, you will learn about data from beehive colonies turned into smart insights, helping us determine the ecological impact humans have in a certain area. In a nutshell, this AI-driven project uses bees as our smart environmental sensors to achieve sustainability goals.
-
December 18, 2023 / 2023
The General Assembly focused on critical issues such as EU pharmaceutical legislation that delivers on accessibility, affordability and availability of the medicines, removing any barriers and delays, and environmental impact.
-
December 14, 2023 / 2023
As a leader in the pan-European pharmaceutical platform, Zentiva actively shares its experience and explores advancements in energy efficiency management through its participation in dedicated events.
-
November 14, 2023 / 2023
We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030.
-
October 24, 2023 / 2023
CPHI is one of the largest and most sought-after event in the pharmaceutical industry. We are excited to meet and discuss with our current, as well as future potential partners.
